ENTRY       D05777                      Drug
NAME        Ruplizumab (USAN/INN)
EFFICACY    Antithrombocytopenia, Immunosuppressant, Anti-CD154 antibody, Anti-CD40 ligand antibody
  TYPE      Monoclonal antibody
COMMENT     Treatment of immune thrombocytopenic purpura and systemic lupus erythematosus
TARGET      TNFSF5 (CD154) [HSA:959] [KO:K03161]
  PATHWAY   hsa04060(959)  Cytokine-cytokine receptor interaction
            hsa04514(959)  Cell adhesion molecules
            hsa04660(959)  T cell receptor signaling pathway
BRITE       Target-based classification of drugs [BR:br08310]
             Cytokines and receptors
              Cytokines
               Tumor necrosis factors
                TNFSF5 (CD154)
                 D05777  Ruplizumab (USAN/INN)
DBLINKS     CAS: 220651-94-5
            PubChem: 47207438
///
